Bank of America
SXTP icon

Bank of America’s 60 Degrees Pharmaceuticals SXTP Stock Holding History

Bank of America’s Portfolio SXTP Stock Details SXTP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-8
Closed -$16 – 6787
2025
Q4 		$16 Hold
8
– – ﹤0.01% 7162
2025
Q3 		$44 Buy
8
+5
+167% +$30 ﹤0.01% 8041
2025
Q2 		$30 Hold
3
– – ﹤0.01% 8190
2025
Q1 		$22 Buy
3
+2
+200% +$25 ﹤0.01% 8123
2024
Q4 		$17 Buy
+1
New +$22 ﹤0.01% 8053
2024
Q3 		– Hold
0
– – – 8063
2024
Q2 		– Hold
0
– – – 8052

Other funds holding SXTP

KCM
Kathmere Capital Management Wayne, Pennsylvania $1.62B AUM 17.7% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return
NA
NewEdge Advisors New Orleans, Louisiana $27.7B AUM 22.98% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return
TPWA
Twin Peaks Wealth Advisors Burlingame, California $397M AUM 23.23% 1-Year Est. Return
Citigroup
Citigroup New York $235B AUM 32.99% 1-Year Est. Return

Bank of America's SXTP Position: Q1 2026 in Review

Bank of America sold out of 60 Degrees Pharmaceuticals (SXTP) in Q1 2026, closing a stake of 8 shares — an estimated $16 sold.

Bank of America first reported a position in SXTP in Q4 2024 and held it in 5 quarters. The position peaked at $44 in Q3 2025. 8 funds tracked by Wall St. Rank hold SXTP as of Q1 2026.

  • Bank of America reported no remaining 60 Degrees Pharmaceuticals position as of Q1 2026 after selling out during the quarter.
  • Bank of America sold 8 60 Degrees Pharmaceuticals shares in Q1 2026, an estimated $16.
  • Bank of America first reported a position in 60 Degrees Pharmaceuticals in Q4 2024 and held it in 5 quarters.
  • Bank of America's 60 Degrees Pharmaceuticals position peaked at $44 in Q3 2025.
  • 8 funds tracked by Wall St. Rank held 60 Degrees Pharmaceuticals as of Q1 2026.

Based on Bank of America's 13F filing for Q1 2026, filed 18 May 2026.